medigraphic.com
ISSN 1817-5996 (Electronic)

2020, Number S1

<< Back Next >>

Rev Cub de Reu 2020; 22 (S1)

Tomography by emission of positrons in the diagnosis of sarcoidosis and Löfgren's syndrome

Reyes LGA, Frías PR, Basulto QN, Mateo DP, Martínez QJA, Gutiérrez RD, Rodríguez MN, Piñera MJ, Herrera PCA

Language: Spanish
References: 27
Page:
PDF size: 573.06 Kb.


ABSTRACT

Sarcoidosis is a multisystemic, non-caseating granulomatous disease of unknown cause that involves the lung and the mediastinal lymph nodes in between 90% and 95% of cases. It can also affect other organs, such as the salivary glands, skin, eyes, liver, spleen, heart, bones, and central nervous system. Thoracic involvement represents the main cause of morbidity and mortality in patients with this entity, which occurs in about 10 / 100,000 people a year. Our study aimed to present a 45-year-old patient treated for presenting clinical, paraclinical and radiological manifestations that allow the diagnosis of an acute form of sarcoidosis to be established without confirming by histological study. Its clinical form of expression showed the presence of Löfgren's syndrome with bilateral mediastinal widening due to hilar lymphadenopathy, febrile syndrome, erythema nodosum, and acute arthritis in the lower limbs, which 20-30% of patients with sarcoidosis develop. A positron emission tomography scan was performed and its results offered us diagnostic elements typical of a pulmonary inflammatory process far from the characteristics of a malignant neoplastic process.


REFERENCES

  1. Martínez Martínez JM, Palacio Vargas KM, Astorga Lahoz MDM, Conde Blanco, Ferrario MC, Aguirre PM. Sarcoidosis al descubierto: Lo que deberíamos informar en las imágenes torácicas. Rev Argent Radiol. 2019 [Acceso 06/09/2020];83(2):77-86. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1020470

  2. Ungprasert P, Crowson CS, Matteson EL. Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota. Reumatismo. 2017 [Acceso 06/09/2020];69(1):16-22. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521258/

  3. Ungprasert P, Carmona EM, Utz JP, Ryu JH, Crowson CS, Matteson EL. Epidemiology of Sarcoidosis 1946-2013: A Population-Based Study. Mayo Clinic Proceedings. 2019 [Acceso 06/09/2020];91(2):183-8. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0025619615008824

  4. Chavarriaga-Restrepo A, López-Amaya JE, Mesa-Navas MA, Velásquez Franco CJ. Sarcoidosis: muchas caras, una enfermedad. Revisión narrativa de la literatura. Latreia. 2019 [Acceso 06/09/2020];32(3):191-203. Disponible en: https://revistas.udea.edu.co/index.php/iatreia/article/view/331778

  5. Mussetti A, Vignoli I, Curbelo P, Meerovich E. Sarcoidosis pulmonar. Neumología Cirugía Tórax. 2006 [Acceso 06/09/2020];65(S3):S36-46. Disponible en: http://alatoldsite.s3.amazonaws.com/images/stories/demo/pdf/intersticiales/EPIntersticialSMNYCT.pdf#page=36

  6. Almaguer-Morales D, Hinojosa-González DE, Garza-Alpirez A. Löfgren Syndrome with Hypercalcemia and Neuro-endocrinological Involvement: A Case Report. Curr Rheumatol Rev. 2019 [Acceso 06/09/2020]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31642787/

  7. Brown F, Tanner LS. Lofgren Syndrome. In StatPearls. Treasure Island (FL): StatPearls Publishing. 2020 [Acceso 06/09/2020]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK482315/

  8. Gatti CF, Prahl, P, Troielli R, Schroh P. Sarcoidosis. Un enfoque global. Med Cutan Iber Lat Am. 2008 [Acceso 06/09/2020];36(4):165-82. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=17452

  9. Sánchez García-Altares MJ, González Sendra FJ, Parra Gordo ML, Lagaña C, Luchsinger Heitmann J, Largo Flores P. Sarcoidosis. Med Gen Fam. 2016 [Acceso 06/09/2020];5(2):71-4. Disponible en: http://mgyf.org/wp-content/uploads/2017/revistas_antes/v05n02_010.pdf

  10. Ishimatsu Y, Koyama H, Tomonaga M, Harada T, Nakashima S, Hara A, et al. Japanese patient with Löfgren's syndrome with an HLA-DR12 allele and review of literature on Japanese patients. Tohoku J Exp Med. 2014 [Acceso 06/09/2020];234(2):137-41. Disponible en: https://www.jstage.jst.go.jp/article/tjem/234/2/234_137/_article/-char/ja/

  11. Rubio-Rivas M, Franco J, Corbella X. Sarcoidosis presenting with and without Löfgren's syndrome: Clinical, radiological and behavioral differences observed in a group of 691patients. Joint Bone Spine. 2020 [Acceso 06/09/2020];87(2):141-7. Disponible en: https://www.sciencedirect.com/science/article/pii/S1297319X19301472

  12. Barahona D. ¿Cuándo solicitar PET/CT en la evaluación de sarcoidosis? Rev Med Chile. 2019 [Acceso 06/09/2020];147(10):1308-14. Disponible en: https://scielo.conicyt.cl/scielo.php?pid=S0034-98872019001001308&script=sci_arttext

  13. Abu-Hilal M, Krotva J, Chichierchio L, Obeidat N, Madanat M. Dermatologic aspects and cutaneous manifestations of sarcoidosis. G Ital Dermatol Venereol. 2010 [Acceso 06/09/2020];145(6):733-45. Disponible en: https://europepmc.org/article/MED/21139550

  14. Blake T, Manahan M, Rodins K. Erythema Nodosum ?A review of an uncommon panniculitis. Dermatol Online J. 2014 [Acceso 06/09/2020];20(4):[aprox. 7 p.]. Disponible en: https://escholarship.org/content/qt2dt0z3mz/qt2dt0z3mz.pdf

  15. Mañá J, Rubio-Rivas M, Villalba N, Marcoval J, Iriarte A, Molina-Molina M, et al. Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain Medicine (Baltimore). 2017 [Acceso 06/09/2020];96(29):e7595. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521941/

  16. Fernández Torquato M, Sousa da Costa MK, Simonsen Nico MM. Cutaneous sarcoidosis: clinico-epidemiological profile of 72 patients at a tertiary hospital in São Paulo, Brazil. An Bras Dermatol. 2019 [Acceso 06/09/2020];95(1):57-62. Disponible en: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000100057

  17. Piérard GE, Piérard-Franchimont C. Erythema nodosum: a panniculitis of diverse origins. Rev Med Liege. 2017 [Acceso 06/09/2020];72(1):43-4. Disponible en: https://europepmc.org/article/med/28387077

  18. Inui N, Murayama A, Sasaki S, Suda T, Chida K, Kato S, et al. Correlation between 25-hydroxyvitamin D3 1 alpha-hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis. Am J Med. 2001 [Acceso 06/09/2020];110(9):687-93. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0002934301007240

  19. Zhao M, Xin XF, Hu H, Pan XH, Lv TF, Liu HB, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of benign pulmonary lesions in sarcoidosis. Transl Lung Cancer Res. 2019 [Acceso 06/09/2020];8(3):208-13. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626856/pdf/tlcr-08-03-208.pdf

  20. Treglia G, Annunziata S, Sobic-Saranovic D, Bertagna F, Caldarella C, Giovanella L. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review. Acad Radiol. 2014 [Acceso 06/09/2020];21(5):675-84. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1076633214000324

  21. Ordóñez-Rubiano EG, Solano-Noguera DF, Row W, Weinberg J, Tatsui CE, Johnson JM, et al. Dual Time-Point 18F-FDG PET/CT in Spinal Sarcoidosis: A Single Institution Case Series. Spine. 2019 [Acceso 06/09/2020];44(21):e1248-55. Disponible en: https://journals.lww.com/spinejournal/Abstract/2019/11010/Dual_Time_Point_18F_FDG_PET_CT_in_Spinal.6.aspx

  22. Larici AR, Glaudemans AW, Del Ciello A, Slart RH, Calandriello L, Gheysens O. Radiological and nuclear medicine imaging of sarcoidosis. Q J Nucl Med Mol Imaging. 2018 [Acceso 06/09/2020];62(1):14-33. Disponible en: https://moh-it.pure.elsevier.com/en/publications/radiological-and-nuclear-medicine-imaging-of-sarcoidosis

  23. Chen H, Jin R, Wang Y, Li L, Li K, He Y. The Utility of 18F-FDG PET/CT for Monitoring Response and Predicting Prognosis after Glucocorticoids Therapy for Sarcoidosis. Biomed Res Int. 2018 [Acceso 06/09/2020];2018:1823710. Disponible en: https://www.hindawi.com/journals/bmri/2018/1823710/

  24. Akaike G, Itani M, Shah H, Ahuja J, Yilmaz Gunes B, Assaker R, et al. PET/CT in the Diagnosis and Workup of Sarcoidosis: Focus on Atypical Manifestations. Radiographics. 2018 [Acceso 06/09/2020];38(5):1536-49. Disponible en: https://pubs.rsna.org/doi/abs/10.1148/rg.2018180053

  25. Hamdi W, Néji O, Ghannouchi MM, Kaffel D, Kchir MM. Rheumatologic manifestations of sarcoidosis. Tunis Med. 2010 [Acceso 06/09/2020];88(11):773-82. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21049404/

  26. Morasert T, Jongjaroonrangsun M, Smithtithiti S, Bhummichitra K. Sarcoidosis with multiorgan involvement. Postgrad Med J. 2019 [Acceso 06/09/2020];96:503-4. Disponible en: https://pmj.bmj.com/content/96/1138/503?utm_campaign=pmj&utm_content=consumer&utm_medium=cpc&utm_source=trendmd&utm_term=usage-042019

  27. Promteangtrong C, Salavati A, Cheng G, Torigian DA, Alavi A. The role of positron emission tomography-computed tomography/magnetic resonance imaging in the management of sarcoidosis patients. Hell J Nucl Med. 2014 [Acceso 06/09/2020];17(2):123-35. Disponible en: https://europepmc.org/article/med/25097898




2020     |     www.medigraphic.com